FDA Inspection
Bell International Laboratories, Inc.Bell International Laboratories, Inc. – FDA Inspection, Jan 29, 2015
Record Details
This FDA Inspection record concerns Bell International Laboratories, Inc., with an inspection on January 29, 2015, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- January 29, 2015
- Product Type
- Drugs
View Company Profile
ID · db949429-bb7f-4c2f-973e-75e5733ce142
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 912298
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
4- 21 CFR 211.110(a)Control procedures to monitor and validate performance
- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
- 21 CFR 211.84(e)Rejecting When Specifications Not Met
- 21 CFR 211.180(e)(2)Items to cover on annual reviews
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Bell International Laboratories, Inc.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| June 12, 2025 | Not classified | Minneapolis District Office | |
| September 19, 2023 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 22, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 14, 2014 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| June 26, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Bell International Laboratories, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.